Our Regulatory Consultancy team are experienced, knowledgeable professionals, able to offer you and your team comprehensive support in developing and implementing your medicines strategy.

Our expertise encompasses all the work that is necessary to receive and maintain a marketing authorisation or registration for medicines, from an initial idea right through to post-authorisation activities. After the expenditure and effort of product development, it is essential to ensure that you get the best out of your investment, through reliable regulatory support.

We recognise that every project and product is unique, and each client has individual needs. That’s why we aim to manage your project with flexibility. Our broad client base, ranging from big pharma to virtual companies with bright ideas has given us experience in how to successfully communicate and manage a wide variety of projects.

JensonR+ can provide regulatory intelligence to you an easy and accessible format. We can help you protect your position, and we can ensure you are making the most out of your pharmaceutical products.

Alongside our extensive EU and UK expertise, JensonR+ also have access to expertise from across global markets through regulanet®, our partner network that has representation in over 90 countries throughout the world and provides a diverse number of services and product expertise across the pharmaceutical and medtech areas.

JensonR+ can also provide joint drug-device guidance and support for combination products through our Medical Device experts across the EU and UK.

Our Services:
JensonR+ can support you with your pharmaceutical product regulatory needs from development through to post-authorisation. Whatever regulatory activity you have in mind, our team of experts can work with you to create a balanced, realistic and achievable strategy that will support your company’s vision, manage and publish your submissions, advise on complex aspects such as Rx-to-OTC switches or Market Access, and support your successful launches.
Come and talk to us for an open and informative discussion, without obligation.